Total Payments
$26,558
2024 Payments
$4,084
Companies
40
Transactions
1,425
Medicare Patients
411
Medicare Billing
$111,703
Payment Breakdown by Category
Food & Beverage$25,938 (97.7%)
Education$380.10 (1.4%)
Other$239.52 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $25,938 | 1,408 | 97.7% |
| Education | $380.10 | 16 | 1.4% |
| Grant | $239.52 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,985 | 130 | $0 (2024) |
| Amgen Inc. | $3,653 | 204 | $0 (2024) |
| Janssen Biotech, Inc. | $2,385 | 159 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,182 | 141 | $0 (2024) |
| UCB, Inc. | $2,136 | 146 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $1,572 | 117 | $0 (2024) |
| Lilly USA, LLC | $1,387 | 94 | $0 (2024) |
| Horizon Therapeutics plc | $1,221 | 71 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,089 | 49 | $0 (2024) |
| PFIZER INC. | $981.82 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,084 | 206 | ANI Pharmaceuticals, Inc. ($651.82) |
| 2023 | $3,975 | 253 | Janssen Biotech, Inc. ($626.91) |
| 2022 | $4,397 | 268 | ABBVIE INC. ($685.22) |
| 2021 | $3,880 | 237 | Amgen Inc. ($664.20) |
| 2020 | $3,480 | 188 | Novartis Pharmaceuticals Corporation ($505.92) |
| 2019 | $3,470 | 140 | AbbVie, Inc. ($770.77) |
| 2018 | $2,085 | 96 | AbbVie, Inc. ($744.69) |
| 2017 | $1,187 | 37 | AbbVie, Inc. ($449.26) |
All Payment Transactions
1,425 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ANI Pharmaceuticals, Inc. | SOVUNA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Treatment of uncomplicated malaria | ||||||
| 12/17/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Analgesic | ||||||
| 12/16/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Immunology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $32.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $1.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/25/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 11/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/20/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: Bone Health | ||||||
| 11/12/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $523.99 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/11/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: Sports Early Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 93 | 1,473 | $91,173 | $39,848 |
| 2022 | 4 | 86 | 1,322 | $89,075 | $36,890 |
| 2021 | 5 | 108 | 234 | $59,597 | $20,864 |
| 2020 | 5 | 124 | 235 | $49,081 | $14,101 |
Total Patients
411
Total Services
3,264
Medicare Billing
$111,703
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 1,260 | $44,100 | $23,374 | 53.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 153 | $41,310 | $14,560 | 35.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 14 | 27 | $5,103 | $1,637 | 32.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 33 | $660.00 | $277.20 | 42.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 1,140 | $39,900 | $19,667 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 135 | $36,450 | $13,001 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $7,055 | $2,332 | 33.1% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 13 | 30 | $5,670 | $1,889 | 33.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 158 | $42,574 | $15,260 | 35.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $6,225 | $2,105 | 33.8% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 12 | 27 | $5,103 | $1,877 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 23 | $4,232 | $1,281 | 30.3% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2021 | 11 | 11 | $1,463 | $341.66 | 23.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 52 | 112 | $30,428 | $9,292 | 30.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 26 | 26 | $10,790 | $3,568 | 33.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 28 | $5,852 | $982.43 | 16.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 14 | 15 | $930.89 | $133.98 | 14.4% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2020 | 14 | 54 | $1,080 | $124.95 | 11.6% |
About Natalie Yanes
Natalie Yanes is a Rheumatology healthcare provider based in South Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1457776940.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Natalie Yanes has received a total of $26,558 in payments from pharmaceutical and medical device companies, with $4,084 received in 2024. These payments were reported across 1,425 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($25,938).
As a Medicare-enrolled provider, Yanes has provided services to 411 Medicare beneficiaries, totaling 3,264 services with total Medicare billing of $111,703. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location South Miami, FL
- Active Since 02/20/2014
- Last Updated 07/26/2019
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1457776940
Products in Payments
- Cimzia (Drug) $1,923
- Enbrel (Biological) $1,848
- ACTHAR (Biological) $1,756
- TREMFYA (Drug) $1,738
- COSENTYX (Biological) $1,720
- TALTZ (Drug) $1,288
- Humira (Biological) $1,171
- BENLYSTA (Biological) $1,043
- RINVOQ (Biological) $1,031
- KRYSTEXXA (Biological) $1,005
- EVENITY (Biological) $979.69
- PURIFIED CORTROPHIN GEL (Drug) $964.34
- XELJANZ (Drug) $940.92
- LUPKYNIS (Drug) $619.15
- Rituxan (Biological) $531.93
- ORENCIA (Biological) $521.46
- SKYRIZI (Biological) $492.17
- Otezla (Drug) $445.46
- COSENTYX (Drug) $441.99
- RAYOS (Drug) $381.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in South Miami
Jaime Pachon, M.d, M.D
Rheumatology — Payments: $66,016
Rheumatology $66,016
Dr. Patricia Mueller, Md, MD
Rheumatology — Payments: $30,889
Rheumatology $30,889
Margarita Garces, M.d, M.D
Rheumatology — Payments: $30,203
Rheumatology $30,203
Mouriel Boucher, Do, DO
Rheumatology — Payments: $8,356
Rheumatology $8,356
Eric Sheldon, M.d, M.D
Rheumatology — Payments: $3,971
Rheumatology $3,971
Dr. Rosita Stoik, M.d, M.D
Rheumatology — Payments: $2,890
Rheumatology $2,890